Genbioma — Pre-seed (estimated) · €400K

Clave invested again in Genbioma, through Navarra Tech Transfer and UN I+D+i Transfer, in a €400k second round. Team members also took part. The money will fund the launch of the first probiotic for prediabetic people.

LeadClave RoundPre-seed (estimated) Announced26 Jan 2021 · as Genbioma Aplicaciones CityNoáin SectorHealthtech & Bio · Biotech Source W

Something wrong? Suggest a correction →